← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR MALARIA
- Institution
- L2 DIAGNOSTICS, LLC, CT
- Principal investigator
- Michel Ledizet
- Funding
- $300K
- Duration
- 2024–2025
Moonbase score
Still being scored
Abstract
This project advances novel diagnostic biomarker discovery and validation for malaria.
LOADING MOONBASE SCORE
Questions for L2 Diagnostics, Llc
L2 Diagnostics, Llc hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same institution, same topic, scored first.
- NIH · L2 Diagnostics, LlcNot yet scored
A Point of Care Test for Babesia microti
Alan Gordon Sutherland · $293K · 2025–2027
- NIH · L2 Diagnostics, LlcNot yet scored
A viral vector-based vaccine to induce humoral and cellular immune protection against Powassan virus in a tick transmission model
Alejandro Marin Lopez · $282K · 2025–2027
- NIH · L2 Diagnostics, LlcNot yet scored
A vaccine targeting mosquito metabolic pathways to eradicate malaria
Yu-Min Chuang · $300K · 2025–2027